NVLX dd part 2
NVLX Management
Dr. Robert F. Ryan, President and CEO:
Dr. Robert F. Ryan was named President and Chief Executive Officer. Dr. Ryan has broad scientific experience in biochemistry, cell and molecular biology, human genetics, novel therapies, and basic and clinical cancer research, having received his Masters in Biochemistry, Cell and Molecular Biology at The Medical College of Georgia, studying sickle cell anemia. He received his Ph.D. in Molecular Genetics at Thomas Jefferson University characterizing DNA and RNA binding properties of zinc finger proteins. Through his extensive training, his experiences extend across the fields of aging, hemoglobinopathies, gene expression, human diseases, DNA, RNA, proteins and their interactions, stem cell research and applications, oncology, clinical protocols and therapies.
Professionally, Dr. Ryan has become a pioneer in the field of emerging biotechnology, specializing in assisting small companies with insight and bringing products to market through the rigorous FDA approval process. Since 2002, Dr. Ryan served as the Chief Executive Officer of RFR Consulting where he focused on helping businesses in the biotech industry through providing information, grant writing, business management, scientific guidance, FDA regulatory advice, advising investors, and investment acquisition opportunities. With 25 years experience including excellent training at the Wistar Institute, NIH, and NCI, he has participated in basic and clinical investigations and has published and edited research articles in several peer-reviewed journals.
http://www.nuvilex.com/management
SHARE HOLDER info: http://www.nuvilex.com/shareholder-info
NVLX International Corporate Headquarters
Nuvilex, Inc.
Meadows Corporate Park I
12510 Prosperity Blvd., Suite #310
Silver Spring, MD 20904
Phone: (877) 598-7616
Fax: (917) 595-2850
email: info@nuvilex.com
NVLX Headline Press Releases
http://finance.yahoo.com/q/h?s=NVLX+Headlines
BFLX SEC Filings
http://www.otcmarkets.com/stock/NVLX/filings
Investigate more about NVLX @ http://www.otcmarkets.com/stock/NVLX/quote for more due diligence.
NVLX Management
Dr. Robert F. Ryan, President and CEO:
Dr. Robert F. Ryan was named President and Chief Executive Officer. Dr. Ryan has broad scientific experience in biochemistry, cell and molecular biology, human genetics, novel therapies, and basic and clinical cancer research, having received his Masters in Biochemistry, Cell and Molecular Biology at The Medical College of Georgia, studying sickle cell anemia. He received his Ph.D. in Molecular Genetics at Thomas Jefferson University characterizing DNA and RNA binding properties of zinc finger proteins. Through his extensive training, his experiences extend across the fields of aging, hemoglobinopathies, gene expression, human diseases, DNA, RNA, proteins and their interactions, stem cell research and applications, oncology, clinical protocols and therapies.
Professionally, Dr. Ryan has become a pioneer in the field of emerging biotechnology, specializing in assisting small companies with insight and bringing products to market through the rigorous FDA approval process. Since 2002, Dr. Ryan served as the Chief Executive Officer of RFR Consulting where he focused on helping businesses in the biotech industry through providing information, grant writing, business management, scientific guidance, FDA regulatory advice, advising investors, and investment acquisition opportunities. With 25 years experience including excellent training at the Wistar Institute, NIH, and NCI, he has participated in basic and clinical investigations and has published and edited research articles in several peer-reviewed journals.
http://www.nuvilex.com/management
SHARE HOLDER info: http://www.nuvilex.com/shareholder-info
NVLX International Corporate Headquarters
Nuvilex, Inc.
Meadows Corporate Park I
12510 Prosperity Blvd., Suite #310
Silver Spring, MD 20904
Phone: (877) 598-7616
Fax: (917) 595-2850
email: info@nuvilex.com
NVLX Headline Press Releases
http://finance.yahoo.com/q/h?s=NVLX+Headlines
BFLX SEC Filings
http://www.otcmarkets.com/stock/NVLX/filings
Investigate more about NVLX @ http://www.otcmarkets.com/stock/NVLX/quote for more due diligence.
